Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252406 · ClinicalTrials.gov registry record · Phase 4
Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT02252406 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 33 participants.
The verdict
NCT02252406, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of ranolazine on different markers of cardiometabolic disease in women with stable angina.
Interventions
- OTHER Placebo
- DRUG Ranolazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-05-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02252406
The ClinicalTrials.gov registry entry for NCT02252406 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02252406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02252406 about?
NCT02252406 is a clinical study titled "Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome". The purpose of this study is to determine the effects of ranolazine on different markers of cardiometabolic disease in women with stable angina.
What is the current status of trial NCT02252406?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2015-09. Estimated completion is 2019-05-17.
What interventions are being tested in trial NCT02252406?
The interventions under investigation include: Placebo (OTHER), Ranolazine (DRUG).
Who is sponsoring clinical trial NCT02252406?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.